Thomas Foster - Cue Health Director

HLTH Stock  USD 0.19  0.01  5.56%   

Director

Mr. Thomas Orion Foster, III is Director of Nobilis Health Corporationration Mr. Foster practiced federal and crossborder taxation for 30 years at Exxon. Mr. Foster presented numerous tax presentations and meetings with various foreign governments on local and U.S. tax issues of concern to U.S. oil companies. He managed state income tax litigation . He coordinated industry efforts to challenge states positions on various tax issues in state and federal courts, including the U.S. Supreme Court. In addition, Mr. Foster private practiced law specializing in tax and restructuring. Mr. Foster received his LLM in taxation from New York University School of Law, his JD from Baylor University School of Law and his BBA from Baylor University School of Business. Mr. Foster is a CPA and admitted to practice law in the State of Texas. Mr. Foster has maintained a private law practice since 1997. In 2010, he joined the Nobilis Board of Directors. In 2011, Mr. Foster joined as its CFO. He resigned that position and began as the companies outside Chief Tax Counsel in February 2012. In July 2014, Mr. Foster was appointed to the Nobilis Board of Directors. Mr. Foster is currently a member of the Nobilis Audit Committee and Compensation Nomination and Corporationrationrate Governance Committee. since 2017.
Age 75
Tenure 7 years
Address 4980 Carroll Canyon Road, San Diego, CA, United States, 92121
Phone858 412 8151
Webhttps://www.cuehealth.com

Cue Health Management Efficiency

The company has return on total asset (ROA) of (0.3188) % which means that it has lost $0.3188 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9035) %, meaning that it created substantial loss on money invested by shareholders. Cue Health's management efficiency ratios could be used to measure how well Cue Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Capital Employed is estimated to decrease to -1.05. The Cue Health's current Return On Assets is estimated to increase to -1.04. As of now, Cue Health's Fixed Asset Turnover is increasing as compared to previous years. The Cue Health's current Asset Turnover is estimated to increase to 0.30, while Non Current Assets Total are projected to decrease to under 212.8 M.
The company currently holds 47.94 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cue Health has a current ratio of 2.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cue Health until it has trouble settling it off, either with new capital or with free cash flow. So, Cue Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cue Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cue to invest in growth at high rates of return. When we think about Cue Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Manuel KadreMednax Inc
54
Aaref HilalyGuardant Health
46
Robert WilliamsLaboratory
72
Donna ShalalaMednax Inc
75
Mary HoeltzelCigna Corp
N/A
Pascal GoldschmidtMednax Inc
65
Robert MittelstaedtLaboratory
74
Paul GabosMednax Inc
55
Garheng KongLaboratory
45
JeanLuc BelingardLaboratory
72
Samir KaulGuardant Health
44
Michelle GassCigna Corp
47
Mark McClellanCigna Corp
57
Richelle ParhamLaboratory
53
Kerrii AndersonLaboratory
63
Eric FossCigna Corp
62
Stanley MeresmanGuardant Health
71
Eric WisemanCigna Corp
65
George KurianCigna Corp
54
Roman MartinezCigna Corp
71
Peter NeupertLaboratory
65
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California. Cue Health operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1585 people. Cue Health (HLTH) is traded on NASDAQ Exchange in USA. It is located in 4980 Carroll Canyon Road, San Diego, CA, United States, 92121 and employs 726 people. Cue Health is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Cue Health Leadership Team

Elected by the shareholders, the Cue Health's board of directors comprises two types of representatives: Cue Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cue. The board's role is to monitor Cue Health's management team and ensure that shareholders' interests are well served. Cue Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cue Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steve Ozonian, Chairman of the Board
Harry Fleming, CEO, Director, Chairman of Acquisition Committee and Chairman of Strategy Committee
Phil Ayres, Chief Marketing Officer
Nitin Duggal, Chief Officer
Thomas Foster, Director
James Springfield, CEO
John Gallagher, Chief Officer
Marcos Rodriguez, Chief Accounting Officer
Kenneth Efird, President
Clint Sever, CoFounder Officer
Donald Kramer, Director
Randall Pollard, Controller Officer
Christopher Achar, Chief Director
Suzanne Stone, Chief Officer
Erica Esq, General Secretary
Lorna Williams, Vice Relations
Kenneth Klein, CFO
Allison Blackwell, Chief Officer
David Arida, Chief Officer
Ayub Khattak, President, CoFounder
Brandon Moreno, CFO
Kenny Klein, CFO, Chief Accounting Officer
Dena Cook, Chief Officer
Jennifer Pfahler, Independent Director
David Young, CFO
Aasim Javed, Treasurer CFO
Richard Ganley, Independent Director
Eileen Sheil, Chief Officer
Michael Nichols, Director
Susan Watt, Director
Neil Badlani, Director
Steven Ozonian, Chairman of the Board
David MD, Chief Officer

Cue Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cue Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Cue Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cue Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cue Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cue Health Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Cue Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Cue Stock please use our How to Invest in Cue Health guide.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Cue Stock analysis

When running Cue Health's price analysis, check to measure Cue Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cue Health is operating at the current time. Most of Cue Health's value examination focuses on studying past and present price action to predict the probability of Cue Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cue Health's price. Additionally, you may evaluate how the addition of Cue Health to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Cue Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cue Health. If investors know Cue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cue Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Earnings Share
(2.44)
Revenue Per Share
0.464
Quarterly Revenue Growth
(0.87)
Return On Assets
(0.32)
The market value of Cue Health is measured differently than its book value, which is the value of Cue that is recorded on the company's balance sheet. Investors also form their own opinion of Cue Health's value that differs from its market value or its book value, called intrinsic value, which is Cue Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cue Health's market value can be influenced by many factors that don't directly affect Cue Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cue Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cue Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cue Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.